Michael S Neuberger

Title: Michael S Neuberger: Innovator in Activation-Induced Cytidine Deaminase Research

Introduction

Michael S Neuberger is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of molecular biology, particularly in the study of activation-induced cytidine deaminase (AID). With a total of 8 patents to his name, Neuberger's work has advanced our understanding of genetic processes and their applications in medicine.

Latest Patents

Among his latest patents, Neuberger has developed functional mutants of activation-induced cytidine deaminase (AID) protein that exhibit increased activity compared to the wild-type AID protein. This invention includes nucleic acids encoding these functional AID mutants, as well as vectors and cells that incorporate these nucleic acids. Additionally, he has patented methods for utilizing these functional mutant AID proteins. Another notable patent focuses on a cell containing a nucleic acid encoding an AID polypeptide, a fusion protein comprising an AID polypeptide, and methods for using a nucleic acid encoding an AID polypeptide.

Career Highlights

Throughout his career, Neuberger has been associated with esteemed institutions such as the Medical Research Council and the Babraham Institute. His research has not only contributed to scientific knowledge but has also paved the way for potential therapeutic applications.

Collaborations

Neuberger has collaborated with notable colleagues, including Julian Edward Sale and Sarah Jane Cumbers. These partnerships have further enriched his research endeavors and have led to significant advancements in the field.

Conclusion

Michael S Neuberger's innovative work in the realm of activation-induced cytidine deaminase has established him as a key figure in molecular biology. His patents and collaborations reflect his commitment to advancing scientific understanding and potential medical applications.